Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5827467 | European Journal of Pharmacology | 2015 | 5 Pages |
Abstract
Animal studies play a central role in the identification and testing of novel drugs for CNS disorders. In his longstanding career, Berend Olivier has significantly contributed to CNS drug discovery by applying and supporting novel views and methodologies in the fields of behavioral neuroscience, pharmacology, and (epi-) genetics. Here we review and put forward some of these integrated approaches that have led to a productive collaboration and new insights into the genetic and epigenetic regulation of neurobehavioural traits related to psychiatric disorders.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Annetrude (J.G.) de Mooij-van Malsen, Eneda Pjetri, Martien J. Kas,